BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 23477558)

  • 1. miRNAs and long noncoding RNAs as biomarkers in human diseases.
    Van Roosbroeck K; Pollet J; Calin GA
    Expert Rev Mol Diagn; 2013 Mar; 13(2):183-204. PubMed ID: 23477558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical aspects of microRNA in diagnostics: a review.
    de Planell-Saguer M; Rodicio MC
    Anal Chim Acta; 2011 Aug; 699(2):134-52. PubMed ID: 21704768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular RNA interference therapy: the broadening tool and target spectrum.
    Poller W; Tank J; Skurk C; Gast M
    Circ Res; 2013 Aug; 113(5):588-602. PubMed ID: 23948584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small noncoding RNAs: biogenesis, function, and emerging significance in toxicology.
    Choudhuri S
    J Biochem Mol Toxicol; 2010; 24(3):195-216. PubMed ID: 20143452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New meaning in the message: noncoding RNAs and their role in retinal development.
    Rapicavoli NA; Blackshaw S
    Dev Dyn; 2009 Sep; 238(9):2103-14. PubMed ID: 19191220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Noncoding RNAs as Biomarkers of Cardiovascular Disease and Injury.
    Viereck J; Thum T
    Circ Res; 2017 Jan; 120(2):381-399. PubMed ID: 28104771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small non-coding RNAs in disease development and host-pathogen interactions.
    Rederstorff M; Hüttenhofer A
    Curr Opin Mol Ther; 2010 Dec; 12(6):684-94. PubMed ID: 21154160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncoding RNAs in molecular characterization of cancer preneoplasia.
    Wang W; Srivastava S
    Cancer Biomark; 2010; 9(1-6):133-40. PubMed ID: 22112473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-coding RNA : Innovative regulators with therapeutic perspective].
    Bührke A; Bär C; Thum T
    Herz; 2018 Mar; 43(2):115-122. PubMed ID: 29236145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA epigenetic alterations: predicting biomarkers and therapeutic targets in human diseases.
    Wang Y; Liang Y; Lu Q
    Clin Genet; 2008 Oct; 74(4):307-15. PubMed ID: 18713257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating long noncoding RNAs as novel biomarkers of human diseases.
    Jiang X; Lei R; Ning Q
    Biomark Med; 2016 Jul; 10(7):757-69. PubMed ID: 27347748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging role of circulating microRNAs as biomarkers in autoimmune diseases.
    Zeng L; Cui J; Wu H; Lu Q
    Autoimmunity; 2014 Nov; 47(7):419-29. PubMed ID: 24953646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).
    Allegra A; Alonci A; Campo S; Penna G; Petrungaro A; Gerace D; Musolino C
    Int J Oncol; 2012 Dec; 41(6):1897-912. PubMed ID: 23026890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA inhibition, microRNAs, and new therapeutic agents for cancer treatment.
    Spizzo R; Rushworth D; Guerrero M; Calin GA
    Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S313-8. PubMed ID: 19778859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational methodologies for studying non-coding RNAs relevant to central nervous system function and dysfunction.
    Majer A; Booth SA
    Brain Res; 2010 Jun; 1338():131-45. PubMed ID: 20381467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs in development and disease.
    Erson AE; Petty EM
    Clin Genet; 2008 Oct; 74(4):296-306. PubMed ID: 18713256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Non-coding RNAs and Cardiovascular Diseases.
    Zhao C; Lv Y; Duan Y; Li G; Zhang Z
    Adv Exp Med Biol; 2020; 1229():357-367. PubMed ID: 32285424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring Noninvasive Biomarkers with the miRandola Database: A Tool for Translational Medicine.
    Russo F
    Methods Mol Biol; 2021; 2284():445-455. PubMed ID: 33835456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frontiers in preclinical safety biomarkers: microRNAs and messenger RNAs.
    Mikaelian I; Scicchitano M; Mendes O; Thomas RA; Leroy BE
    Toxicol Pathol; 2013 Jan; 41(1):18-31. PubMed ID: 22659243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-coding RNAs and cancer: new paradigms in oncology.
    Lee SK; Calin GA
    Discov Med; 2011 Mar; 11(58):245-54. PubMed ID: 21447283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.